R21/Matrix-M - University of Oxford, Serum Institute of India
Mosquirix (RTS,S) - GSK
LARC-GAPs: emerging whole-sporozoite vaccines for high-level sterile protection against malaria. (PubMed, Trends Parasitol) - Oct 7, 2026 - "Despite the recent deployment of the RTS,S/AS01 and R21/Matrix-M vaccines, malaria cases and deaths continue to increase...Recent studies have shown that late liver-stage-arresting, replication-competent (LARC)-GAPs elicit broader immune responses and provide better protection than other malaria vaccines. Here, we highlight the development of GAP vaccines, compare early-arresting GAPs and LARC-GAPs, discuss recent clinical data, and assess their translational potential as next-generation malaria vaccines." 
Journal • Review • Infectious Disease • Malaria
http://www.ncbi.nlm.nih.gov/pubmed/42838833
 
Indrani Chakraborty; Plabita Paul; Raksha Devi; Satish Mishra
 
Oct 7, 2026
 
Prev Next